Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis
- 25 August 2010
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 30 (9) , 1371-1378
Abstract
Variceal bleeding in cirrhosis can cause liver ischaemia and deteriorate the hyperdynamic state; thus, the effects of vasoconstrictor therapy on liver blood volume (LBV) and thorax blood volume (ThBV) are important. To evaluate and compare the effects of terlipressin and somatostatin on LBV and ThBV in stable patients with cirrhosis and portal hypertension. Twenty patients were studied (Child-Pugh class A/B/C: 5/8/7). The radioactivities in the liver region (LRR) and the thorax region (ThRR) by single-head gamma camera technique, as indicators of LBV and ThBV, respectively, and systemic haemodynamics were measured at baseline and after intravenous infusion of 2 mg of terlipressin (n=10) or somatostatin 250 mg/h after an initial bolus of 250 mg (n=10). LRR and ThRR decreased significantly with increasing severity of cirrhosis. Thirty minutes after terlipressin infusion, LRR and ThRR increased by 7.8 ± 4.4% (NS) and 14 ± 5.3% (P=0.01) compared with baseline values; the increase in ThRR was significantly related to the increase in LRR (r=0.682, P=0.03). In contrast, somatostatin reduced LRR and ThRR by 13.3 ± 6.5% (P=0.07) and 1 ± 4% (NS) respectively. LRR and ThRR increased significantly in the terlipressin group compared with the somatostatin group (P=0.01 and P=0.02 respectively). Terlipressin reduced cardiac output and heart rate (both P=0.01) and increased the mean arterial pressure (MAP) and systemic vascular resistance (P=0.009 and P=0.002 respectively); MAP decreased after somatostatin infusion (P=0.03). Terlipressin, but not somatostatin, maintains LBV, increases ThBV and improves the hyperdynamic state in cirrhosis. These effects can be beneficial in variceal bleeding, particularly in patients with advanced liver disease.Keywords
This publication has 35 references indexed in Scilit:
- Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosisJournal of Gastroenterology and Hepatology, 2009
- Cardiovascular complications of cirrhosisGut, 2008
- Three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhageThe Korean Journal of Hepatology, 2008
- Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosisJournal of Gastroenterology and Hepatology, 2005
- Time profile of the haemodynamic effects of terlipressin in portal hypertensionJournal of Hepatology, 1997
- Ischemic Hepatitis in CirrhosisJournal of Clinical Gastroenterology, 1996
- Somatostatin does not reduce oesophageal variceal pressure in liver cirrhotics.Gut, 1988
- Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in manBritish Journal of Surgery, 1985
- Vasopressin and Hepatic ArteryInvestigative Radiology, 1975
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973